Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Reyvow
Synonyms :
lasmiditan
Class :
Antimigraine Agents
Brand Name :
Reyvow
Synonyms :
lasmiditan
Class :
Antimigraine Agents
Dosage Forms & Strengths Â
Tablet  Â
50mg Â
100mg Â
200mg Â
Indicated for acute migraine
50 mg or 100 mg, or 200 mg orally as needed
Do not exceed > 1 dose a day
may increase the QTc prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of each other when combined
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when it is combined
may enhace the serum concentration of each other when it is combined
may enhace the serum concentration of each other when it is combined
may enhace the serum concentration of each other when it is combined
may enhace the serum concentration of each other when it is combined
may enhace the serum concentration of each other when it is combined
may increase the serum concentration of each other when it is combined
may increase the serum concentration of each other when it is combined
may increase the serum concentration of each other when it is combined
may increase the serum concentration of each other when it is combined
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
when both drugs are combined, there may be an increased level of serum concentration of alpelisib   
it increases brentuximab vedotin level with the help of (MDR1) P-glycoprotein efflux transporter.
increase serum level of daunorubicin by P-glycoprotein efflux transporter
lasmiditan, when taken with lapatinib, simultaneously increases the effect of one another
increase serum level of idarubicin by P-glycoprotein efflux transporter
it increases the level of rifaximin with the help of the P-glycoprotein (MDR1) efflux transporter
it increases the effect of sitagliptin via the MDR1 efflux transporter
it increases the effect of linagliptin via the MDR1 efflux transporter
may enhance the level of each other when combined
may enhance the level of each other when combined
may increase the level of effectiveness through P-glycoprotein MDR1 efflux transporter
may enhance the serum concentration of P-glycoprotein/ABCB1 Substrates
lasmiditan and mephenesin, when used together, the risk or seriousness of adverse events may rise
it increases the effect of serotonergic agents
It may enhance the risk of adverse effects when combined with Fluoroquinolones
It may enhance the risk of adverse effects when combined with Fluoroquinolones
It may enhance the risk of adverse effects when combined with Fluoroquinolones
It may enhance the risk of adverse effects when combined with Fluoroquinolones
It may enhance the risk of adverse effects when combined with Fluoroquinolones
when both drugs are combined, there may be an increased level of serum concentration of etoposide   
when both drugs are combined, there may be an increased level of serum concentration of vinblastine  
May enhances the effects of the other by pharmacodynamic synergism
may increase the arrhythmogenic effect of Inhalational Anaesthetics
It may diminish the metabolism when combined with Melatonin
It may diminish the metabolism when combined with Melatonin
It may diminish the metabolism when combined with Melatonin
It may diminish the metabolism when combined with Melatonin
It may enhance the risk of adverse effects when combined with protein kinase inhibitors
It may enhance the risk of adverse effects when combined with protein kinase inhibitors
It may enhance the risk of adverse effects when combined with protein kinase inhibitors
It may enhance the risk of adverse effects when combined with protein kinase inhibitors
It may enhance the risk of adverse effects when combined with protein kinase inhibitors
Adverse drug reactions Â
Frequency Defined Â
>10% Â
Dizziness (9-17%) Â
1-10% Â
Nausea and vomiting (3-4%) Â
Sedation (6-7%) Â
Paresthesia (3-9%) Â
Muscle weakness (1-2%) Â
Fatigue (4-6%) Â
<2% Â
Palpitations Â
Vertigo Â
Visual impairment Â
Incoordination Â
Lethargy Â
Anxiety Â
Feeling abnormal Â
Â
Pregnancy warnings:   
US FDA pregnancy category: Not assignedÂ
Lactation: Â
The drug excretion in breast milk is unknown. Â
Pregnancy Categories:       Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category Â
Patient Information Leaflet Â
Generic Name: lasmiditanÂ
Why do we use lasmiditan? Â
lasmiditan is an Antimigraine Agent used to treat acute migraine.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
